SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-001125
Filing Date
2021-01-05
Accepted
2021-01-05 19:01:36
Documents
2
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211606-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm211606-7_4seq1.xml 4 7882
2 EXHIBIT 24.1 tm211606d7_ex24-1.htm EX-24.1 7815
  Complete submission text file 0001104659-21-001125.txt   17186
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Pruzanski Mark (Reporting) CIK: 0001559569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 21508074